Post-earnings recap
Reported
Thu, May 1, 2025
EPS actual
$3.34
EPS est.
$3.52
EPS surprise
-5.01%
1-day move
-11.66%
Eli Lilly's earnings report indicates a slight miss on EPS, which contributed to a significant drop in stock price by 11.66%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. Management's defensive tone suggests they are aware of the challenges ahead but remain focused on long-term growth through R&D investments.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.34 | N/A | -5.01% |
Overall, management expressed concern over recent performance but highlighted their commitment to innovation. They did not provide specific guidance for the upcoming quarters.
Management acknowledged challenges in meeting earnings expectations.
They emphasized ongoing investments in research and development.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—